Key result
Electrical vagal nerve stimulation significantly decreased mean pulmonary arterial pressure, attenuated pulmonary vascular remodeling, and improved survival in rats with severe pulmonary hypertension.
Why the study?
Does electrical vagal nerve stimulation improve survival and pulmonary hemodynamics in a rat model of severe pulmonary arterial hypertension?
Does electrical vagal nerve stimulation improve survival and pulmonary hemodynamics in a rat model of severe pulmonary arterial hypertension?
Electrical vagal nerve stimulation improves survival and attenuates pulmonary vascular remodeling in a rat model of severe pulmonary arterial hypertension, suggesting a potential novel therapeutic strategy.
This study aimed to elucidate the therapeutic effects of electrical vagal nerve stimulation (VNS) on severe pulmonary arterial hypertension in a rat model. In a pathophysiological study, VNS significantly restored autonomic balance, decreased mean pulmonary arterial pressure, attenuated pulmonary vascular remodeling, and preserved right ventricular function. In a survival study, VNS significantly improved the survival rate in both the prevention (VNS from 0 to 5 weeks after a SU5416 injection) and treatment (VNS from 5 to 10 weeks) protocols. Thus, VNS may serve as a novel therapeutic strategy for pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2018) studied severe pulmonary arterial hypertension. Electrical vagal nerve stimulation was evaluated on Survival rate and pathophysiological parameters (autonomic balance, mean pulmonary arterial pressure, pulmonary vascular remodeling, right ventricular function). Electrical vagal nerve stimulation significantly decreased mean pulmonary arterial pressure, attenuated pulmonary vascular remodeling, and improved survival in rats with severe pulmonary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: